To gain an insight into IGF2BP2 in NSCLC progression, we ectopically expressed IGF2BP2 in A549 cells (Figures 2A,B) and generated IGF2BP2 knockdown in H1975 cells (Figures 2C,D). The gene discussed is IGF2BP2; the disease is non-small cell lung carcinoma.